3 Reasons Why I Remain Bullish On SCHB, And 2 To Sell It Immediately

0.03%: Schwab U.S. Broad Market ETF provides low-cost, core US equity exposure with a 0.03% expense ratio and broad diversification. Forward valuations, especially in technology, have normalized to historical averages, but rising corporate CAPEX and uncertain EPS growth—combined with geopolitical risks and inflation-driven consumer spending contraction—temper enthusiasm and imply that apparent valuation discounts may be illusory.

Analysis

Rising corporate CAPEX is a hidden bifurcation: capital‑goods and industrial suppliers (semiconductor equipment, heavy electrical, industrial automation) are positioned to convert order funnels into above‑market cashflow over 6–18 months, while end‑demand exposed consumer discretionary and small‑cap domestic cyclicals face margin compression if input costs or service‑led spending diverge. Supply‑chain second‑order winners include industrial power suppliers, specialty chemicals and energy services where multi‑quarter backlog and lead times give pricing power; losers are just‑in‑time assemblers and low‑margin retail logistics that cannot pass through higher freight/energy costs without losing volume.

Tail risks cluster around geopolitics and inflation persistence: a supply shock (Taiwan Strait escalation or new tariffs) would hit semiconductors and re-rate risk premia within days; sustained sticky inflation that keeps real rates higher for >6 months would compress P/E on low‑growth names and force rotation into real‑asset cash generators. Near‑term catalysts to watch are capex order books reported in the next two earnings cycles, CPI prints over the next three months, and how guidance for 2H corporate buybacks/dividends evolves — each can re‑accelerate or reverse the current dispersion.

Contrarian lens: consensus treats normalized multiples as a ceiling, but it understates optionality from AI productivity gains concentrated in a handful of capex‑intensive vendors — if AI monetization drives even a 5–10% uplift to medium‑term revenue growth for these suppliers, their cashflow will re‑rate materially. Conversely, the market may be masking true downside in breadth: headline discounts in broad indices can be illusory if median company EPS is trending down; that asymmetry argues for selective exposure, not a blunt long‑market trade.

Key Decisions for Investors

• Buy a 6–12 month call spread on AMAT (Applied Materials) sized to 1–2% portfolio: bullish on sustained semiconductor CAPEX translating to stronger orders; structure for 2–3x upside vs limited premium decay risk if orders slip.
• Initiate a pair: long PG (Procter & Gamble) 3–6 month position vs short XLY (Consumer Discretionary ETF) — expected outperformance if inflation‑sensitive consumption retrenches; target 4–8% portfolio tilt with stop‑loss at 6% drawdown on the long leg.
• Protect small‑cap exposure: buy a 3‑month IWM put spread (moderately OTM) sized to hedge 50% of your small‑cap beta — low cost hedge that pays off on a cyclical selloff driven by consumption or rate shocks.
• Trim SCHB exposure by 10–15% and redeploy into industrial/specialty suppliers (example: LRCX or HON) over 6–12 months — reduces breadth risk while keeping equity beta; catalyst‑driven trade with asymmetric upside if capex tails materialize.
• Set an event trigger: if semicap order books (next two quarters) beat guidance by >10%, add to capex supplier exposure (AMAT/LRCX) and take profits on discretionary shorts; if order books miss by >10%, tighten stops and increase hedges within 1–3 weeks.